BamSEC and AlphaSense Join Forces
Learn More

Vistagen Therapeutics Inc.

NASDAQ: VTGN    
Share price (1/6/25): $3.20    
Market cap (1/6/25): $89.1 million

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Restated and Amended Articles of Incorporation of VistaGen Therapeutics, Inc
12/34/56
EX-3.5
from 10-Q 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.4
from 10-Q 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.3
from 10-Q 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from 10-Q 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 2 to the Second Amended and Restated Bylaws of VistaGen Therapeutics, Inc. Approved by the Board of Directors on August 30, 2022
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Restated and Amended Articles of Incorporation
12/34/56
EX-3.1
from 8-K 11 pages Certificate of Designation of the Relative Rights and Preferences of the Series D Convertible Preferred Stock of VistaGen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Restated and Amended Articles of Incorporation of VistaGen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Restated and Amended Articles of Incorporation of VistaGen Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 14 pages Second Amended and Restated Bylaws of VistaGen Therapeutics, Inc., a Nevada Corporation
12/34/56
EX-3.1
from 8-K 4 pages Restated Articles of Incorporation of VistaGen Therapeutics, Inc
12/34/56
EX-3
from 8-K 11 pages Certificate of Designation of the Relative Rights and Preferences of the Series C Convertible Preferred Stock of VistaGen Therapeutics, Inc
12/34/56
EX-3
from 8-K 1 page Certificate of Amendment to Articles of Incorporation of VistaGen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 17 pages Certificate of Designation of the Relative Rights and Preferences of the Series B 10% Convertible Preferred Stock of VistaGen Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Change of Vistagen Therapeutics, Inc., Filed August 11, 2014
12/34/56
EX-3
from 8-K 15 pages Amended and Restated Bylaws of VistaGen Therapeutics, Inc., a Nevada Corporation
12/34/56
EX-3.3
from 10-K 1 page Certificate of Amendment (Pursuant to Nrs 78.386 and 78,390) Use Black Ink Only. Do Not Highlight Above Space Is for Office Use Only Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56
EX-3.2
from 10-K 7 pages Use Black Ink Only • Do Not Highlight Above Space Is for Office Use Only Articles of Merger
12/34/56
EX-3
from 8-K 3 pages Certificate of Designation of the Relative Rights and Preferences of the Series a Convertible Preferred Stock of VistaGen Therapeutics, Inc
12/34/56